Assembly Biosciences to Present at Upcoming Investor Conferences
Assembly Biosciences Announces Upcoming Investor Conference Presentations
Image: Benzinga
Assembly Biosciences, Inc. will participate in fireside chats at the Jefferies 2026 Global Healthcare Conference on June 3 and the Goldman Sachs 47th Annual Global Healthcare Conference on June 8. The company focuses on developing therapeutics for serious viral and liver diseases.
- 01Assembly Biosciences will present at the Jefferies 2026 Global Healthcare Conference on June 3 at 4:20 p.m. ET.
- 02The company will also participate in the Goldman Sachs 47th Annual Global Healthcare Conference on June 8 at 8:40 a.m. ET.
- 03Assembly Biosciences specializes in therapeutics targeting herpesvirus, hepatitis delta virus (HDV), cholestatic liver diseases, and hepatitis B virus (HBV).
- 04The company is led by experts in antiviral and liver disease drug development.
- 05Webcasts of the presentations will be available on the company's investor relations website.
Advertisement
In-Article Ad
Assembly Biosciences, Inc. (NASDAQ:ASMB), a biotechnology firm based in South San Francisco, California, announced its participation in two upcoming investor conferences. Senior management will engage in fireside chats at the Jefferies 2026 Global Healthcare Conference on June 3, 2026, at 4:20 p.m. ET, and at the Goldman Sachs 47th Annual Global Healthcare Conference on June 8, 2026, at 8:40 a.m. ET. Assembly Biosciences focuses on developing innovative small-molecule therapeutics aimed at serious viral and liver diseases, including herpesvirus, hepatitis delta virus (HDV), cholestatic liver diseases, and hepatitis B virus (HBV). The company is committed to improving patient outcomes through advanced treatment options. Interested parties can register for the webcasts via the Events and Presentations section of Assembly Bio's website, where replays will also be accessible post-event.
Advertisement
In-Article Ad
Advertisement
In-Article Ad
Reader Poll
What do you think about the future of biotechnology investments?
Connecting to poll...
Read the original article
Visit the source for the complete story.





